NewLink Genetics CorporationNLNK was a big mover last session, as the company saw its shares rise almost 10% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This reverses the recent trend of the company, as the stock is now down 15% in the past one-month time frame.
None of the estimates for this stock were revised in the last 30 days, while the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
NewLink Genetics carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
NEWLINK GENETIC Price
A better-ranked stock in the same industry is Arbutus Biopharma Corporation ABUS , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .
Zacks' Top Investment Ideas for Long-Term Profit
How would you like to see our best recommendations to help you find today's most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report